ORGANIZATION BUSINESS AND LIQUIDITY (Details Narrative) - USD ($)		1 Months Ended	12 Months Ended
	Jul. 10, 2023	Jul. 30, 2022	Dec. 31, 2023	Dec. 31, 2022	Dec. 01, 2022	Sep. 01, 2022	Aug. 29, 2022
Promissory notes convertible to shares		200,000
Common Stock sold						100,000
Common Stock for total gross proceeds						$ 6,000,000
Net proceeds for common stock						$ 5,468,813
Ownership percentage	50.00%
Contingent liability at lease inception		$ 4,000,000
Allocated as machinery		3,400,000
Allocated as trademarks		600,000
Equipment value		$ 2,278,337
One-time charge				$ 1,121,663
Net loss			$ (13,442,221)	(7,134,957)
Net cash used in operating activities			$ (5,844,807)	$ (4,370,476)
Common stock par value		$ 20.00	$ 0.001	$ 0.001
Accumulated deficit			$ (23,588,666)	$ (10,463,048)
Green Star Labs [Member]
Total purchase price to be paid			$ 3,500,000
Description of payment of purchase equipment			The purchase price was allocated as to $1,776,000 for purchase of Green Star Labs, and $1,724,000 for the equipment. $3,200,000 of the $3,500,000 (a cash deposit of $300,000 was paid prior to closing) total purchase price was payable by the Company’s issuance of a convertible promissory note to the seller, which became effective on July 10, 2023.
Hamburg Germany [Member]
Issuance of common Stock					1,500
Common Stock for compensation					$ 50,000
Underwriters [Member]
Offering price to the public						$ 90.00	$ 60.00
Common stock available for sale			100,000
Warrrants issued to purchase common stock						7,000
Additional shares of Common Stock offered for sale			15,000
Hempacco Co Inc [Member]
Ownership percentage			50.00%
Paid for equity			$ 300,000